| Michael P Churchin, CRNA | |
|
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
| (888) 988-2800 | |
| Not Available |
| Full Name | Michael P Churchin |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 441 N Lakeview Ave, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437350329 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | NA2089 (California) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand through a patient's skin and bone, and the procedure is often described as extremely painful.
Sarpogrelate, an antiplatelet medication, has potential as a new heart failure therapy and, according to researchers, could potentially decrease health care costs associated with cardiovascular disease, according to preliminary animal research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael P Churchin, CRNA 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Michael P Churchin, CRNA 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand through a patient's skin and bone, and the procedure is often described as extremely painful.
Sarpogrelate, an antiplatelet medication, has potential as a new heart failure therapy and, according to researchers, could potentially decrease health care costs associated with cardiovascular disease, according to preliminary animal research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
› Verified 2 days ago
Laura Koh, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3440 E La Palma Ave, Anaheim, CA 92806 Phone: 714-644-2000 | |
Teresa Huang, RN, MSN, FNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3440 E La Palma Ave, Anaheim, CA 92806 Phone: 714-644-2000 | |
Carol J Wesner, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Carol A Dilibero, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4487 | |
Edward H Marthaler, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Susan M Heravi, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Tracy L Ouzounian, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |